We are live on ! Find out more
ACM

Ativo Capital Management Portfolio holdings

AUM $115M
1-Year Est. Return 19.02%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+19.02%
3 Year Est. Return
+57.9%
5 Year Est. Return
+80.23%
10 Year Est. Return
+460.95%
AUM
$373M
AUM Growth
+$6.37M
Cap. Flow
-$15M
Cap. Flow %
-4.03%
Top 10 Hldgs %
19.34%
Holding
254
New
36
Increased
74
Reduced
58
Closed
38

Sector Composition

Rank Sector Weight
1 Technology 25.44%
2 Financials 16.59%
3 Industrials 13.75%
4 Consumer Discretionary 11.99%
5 Healthcare 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEET
251
DELISTED
The Meet Group, Inc. Common Stock
MEET
-223,048
Closed -$1.13M
DCM
252
DELISTED
NTT DOCOMO, Inc.
DCM
-77,629
Closed -$1.84M
SNC
253
DELISTED
State National Companies, Inc.
SNC
-70,018
Closed -$1.29M

Similar funds

Ativo Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Ativo Capital Management held 254 positions worth $373M, up 1.7% from $366M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ativo Capital Management withdrew a net $15M in Q3 2017, closing 38 positions and reducing 58 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $7.68M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ativo Capital Management opened a new position in Vedanta Limited American Depostary Shares (Each representing four equity shares) worth $7.18M.

  • Ativo Capital Management's largest Q3 2017 buy was Vedanta Limited American Depostary Shares (Each representing four equity shares): 371,120 shares worth $7.18M.
  • Ativo Capital Management added most to KB Financial Group in Q3 2017, an estimated $1.98M increase.
  • Ativo Capital Management's biggest Q3 2017 reduction was TSMC, cutting an estimated $2.44M.
  • Ativo Capital Management fully exited China Biologic Products Holdings, Inc. in Q3 2017, selling an estimated $7.68M.
  • Ativo Capital Management's ten largest holdings make up 19% of its $373M portfolio in Q3 2017.
  • Ativo Capital Management opened 36 new positions and closed 38 in Q3 2017.
  • Ativo Capital Management's portfolio value rose 1.7% quarter-over-quarter to $373M.

Based on Ativo Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.